Gut microbiota in phytopharmacology: A comprehensive overview of concepts, reciprocal interactions, biotransformations and mode of actions

被引:159
作者
Dey, Priyankar [1 ]
机构
[1] Ohio State Univ, Dept Human Sci, Human Nutr Program, Columbus, OH 43210 USA
关键词
Biotransformation; Microbiota; Nutrition; Obesity; Pharmacology; Phytochemicals; HIGH-FAT-DIET; TIGHT JUNCTION PERMEABILITY; INTESTINAL BARRIER FUNCTION; HIGH-PROTEIN DIET; AKKERMANSIA-MUCINIPHILA; IN-VITRO; BETA-GLUCURONIDASE; INSULIN-RESISTANCE; FECAL MICROFLORA; HEPATIC-INJURY;
D O I
10.1016/j.phrs.2019.104367
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The dynamic and delicate interactions amongst intestinal microbiota, metabolome and metabolism dictates human health and disease. In recent years, our understanding of gut microbial regulation of intestinal immunometabolic and redox homeostasis have evolved mainly out of in vivo studies associated with high-fat feeding induced metabolic diseases. Techniques utilizing fecal transplantation and germ-free mice have been instrumental in reproducibly demonstrating how the gut microbiota affects disease pathogenesis. However, the pillars of modern drug discovery i.e. evidence-based pharmacological studies critically lack focus on intestinal microflora. This is primarily due to targeted in vitro molecular-approaches at cellular-level that largely overlook the etiology of disease pathogenesis from the physiological perspective. Thus, this review aims to provide a comprehensive understanding of the key notions of intestinal microbiota and dysbiosis, and highlight the microbiota-phytochemical bidirectional interactions that affects bioavailability and bioactivity of parent phytochemicals and their metabolites. Potentially by focusing on the three major aspects of gut microbiota i.e. microbial abundance, diversity, and functions, I will discuss phytochemical-microbiota reciprocal interactions, biotransformation of phytochemicals and plant-derived drugs, and pre-clinical and clinical efficacies of herbal medicine on dysbiosis. Additionally, in relation to phytochemical pharmacology, I will briefly discuss the role of dietary-patterns associated with changes in microbial profiles and review pharmacological study models considering possible microbial effects. This review therefore, emphasize on the timely and critically needed evidence-based phytochemical studies focusing on gut microbiota and will provide newer insights for future pre-clinical and clinical phytopharmacological interventions.
引用
收藏
页数:17
相关论文
共 181 条
[1]
Curcumin Differs from Tetrahydrocurcumin for Molecular Targets, Signaling Pathways and Cellular Responses [J].
Aggarwal, Bharat B. ;
Deb, Lokesh ;
Prasad, Sahdeo .
MOLECULES, 2015, 20 (01) :185-205
[2]
Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form [J].
Akao, T ;
Kawabata, K ;
Yanagisawa, E ;
Ishihara, K ;
Mizuhara, Y ;
Wakui, Y ;
Sakashita, Y ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (12) :1563-1568
[3]
Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng [J].
Akao, T ;
Kida, H ;
Kanaoka, M ;
Hattori, M ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (10) :1155-1160
[4]
A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice [J].
Anhe, Fernando F. ;
Roy, Denis ;
Pilon, Genevieve ;
Dudonne, Stephanie ;
Matamoros, Sebastien ;
Varin, Thibault V. ;
Garofalo, Carole ;
Moine, Quentin ;
Desjardins, Yves ;
Levy, Emile ;
Marette, Andre .
GUT, 2015, 64 (06) :872-883
[5]
[Anonymous], DIABETES
[6]
[Anonymous], J ETHNOPHARMACOL
[7]
[Anonymous], 2019, HEPATOLOGY
[8]
[Anonymous], MSYSTEMS
[9]
[Anonymous], J EVID BASED COMPLEM
[10]
[Anonymous], ALTERN MED